A multiple-center comparative study of the kidney tolerance of ceftazidime versus cefotaxime and tobramycin.
Mondorf
A
A
Center of Internal Medicine, University of Frankfurt, Federal Republic of Germany.
Mondorf
W
W
Banzer
S
S
D000626:Aminopeptidases / Q000652:urine*; D015415:Biomarkers / Q000652:urine*; D018826:CD13 Antigens; D002439:Cefotaxime / Q000009:adverse effects*; D002442:Ceftazidime / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D015337:Multicenter Studies as Topic; D014031:Tobramycin / Q000009:adverse effects*
D015415:Biomarkers; D002442:Ceftazidime; D000626:Aminopeptidases; D018826:CD13 Antigens; D002439:Cefotaxime; D014031:Tobramycin